A ranking of pharma companies developing new medicines for low- and middle-income countries has revealed that just five companies are responsible for almost two-thirds of projects.
A new report published by Research2Guidance has shown that the chances of major pharmaceutical companies to launch successful apps have decreased from 2.0% in 2014 to 0.5% in 2016.